A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).
Andrew T RajczewskiSubina MehtaDinh Duy An NguyenBjörn GrüningJames E JohnsonThomas McGowanTimothy J GriffinPratik D JagtapPublished in: Clinical proteomics (2021)
We propose that these peptides would be of the most value for clinical proteomics applications seeking to detect COVID-19 from patient samples. We also contend that samples harvested from the upper respiratory tract and oral cavity have the highest potential for diagnosis of SARS-CoV-2 infection from easily collected patient samples using mass spectrometry-based proteomics assays.